AbbVie Data Show Skyrizi Tops IL-17 Competitors In Skin Clearance

AbbVie Building
AbbVie's head-to-head psoriasis data showed Skyrizi bests the IL-17 class • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D